PL356802A1 - Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors - Google Patents

Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors

Info

Publication number: PL356802A1
Authority: PL; Poland
Prior art keywords: pyrido; pyrimidine; diamine; kinase inhibitors; kinase
Prior art date: 2000-01-25

Application number

PL01356802A

Other languages

English (en)

Polish (pl)

Inventor

Richard John Booth

Ellen Myra Dobrusin

Vara Prasad Venkata Nagendra Josyula

Dennis Joseph Mcnamara

Peter Laurence Toogood

Original Assignee

Warner-Lambert Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-25

Filing date

2001-01-23

Publication date

2004-07-12

2001-01-23 Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company

2004-07-12 Publication of PL356802A1 publication Critical patent/PL356802A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Enzymes And Modification Thereof (AREA)

PL01356802A 2000-01-25 2001-01-23 Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors PL356802A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17826100P	2000-01-25	2000-01-25
PCT/IB2001/000069 WO2001055147A1 (en)	2000-01-25	2001-01-23	PYRIDO[2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS

Publications (1)

Publication Number	Publication Date
PL356802A1 true PL356802A1 (en)	2004-07-12

Family

ID=22651853

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01356802A PL356802A1 (en)	2000-01-25	2001-01-23	Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors

Country Status (34)

Country	Link
EP (1)	EP1254137A1 (et)
JP (1)	JP4047010B2 (et)
KR (1)	KR20020065939A (et)
CN (1)	CN1395578A (et)
AP (1)	AP2002002586A0 (et)
AR (1)	AR030044A1 (et)
AU (1)	AU2542501A (et)
BG (1)	BG106850A (et)
BR (1)	BR0107751A (et)
CA (1)	CA2397961C (et)
CO (1)	CO5261549A1 (et)
CR (1)	CR6706A (et)
CZ (1)	CZ20022475A3 (et)
DZ (1)	DZ3266A1 (et)
EA (1)	EA200200643A1 (et)
EE (1)	EE200200405A (et)
GT (1)	GT200100016A (et)
HN (1)	HN2001000013A (et)
HU (1)	HUP0204141A3 (et)
IL (1)	IL150545A0 (et)
IS (1)	IS6443A (et)
MA (1)	MA26868A1 (et)
MX (1)	MXPA02007221A (et)
NO (1)	NO20023527L (et)
OA (1)	OA12161A (et)
PA (1)	PA8510701A1 (et)
PE (1)	PE20011066A1 (et)
PL (1)	PL356802A1 (et)
SK (1)	SK10632002A3 (et)
SV (1)	SV2002000294A (et)
TN (1)	TNSN01014A1 (et)
WO (1)	WO2001055147A1 (et)
YU (1)	YU50402A (et)
ZA (1)	ZA200205879B (et)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
CN1847229B (zh)	2000-10-23	2011-05-04	史密丝克莱恩比彻姆公司	2，4，8-三取代-8H-吡啶并[2，3-d]嘧啶-7-酮化合物
PE20030008A1 (es) *	2001-06-19	2003-01-22	Bristol Myers Squibb Co	Inhibidores duales de pde 7 y pde 4
EP1499320B1 (en)	2002-04-19	2007-08-22	Smithkline Beecham Corporation	Novel compounds
US7504410B2 (en) *	2002-11-28	2009-03-17	Schering Aktiengesellschaft	Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
US7157455B2 (en) *	2003-02-10	2007-01-02	Hoffmann-La Roche Inc.	4-Aminopyrimidine-5-one derivatives
TW200502236A (en) *	2003-03-28	2005-01-16	Hoffmann La Roche	Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
FR2873118B1 (fr)	2004-07-15	2007-11-23	Sanofi Synthelabo	Derives de pyrido-pyrimidine, leur application en therapeutique
EP1794160A1 (en) *	2004-09-21	2007-06-13	F.Hoffmann-La Roche Ag	6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as proteine kinase inhibitors
EP1868612A4 (en)	2005-03-25	2010-03-24	Glaxo Group Ltd	NOVEL CONNECTIONS
PE20061193A1 (es)	2005-03-25	2006-12-02	Glaxo Group Ltd	DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
UY29440A1 (es)	2005-03-25	2006-10-02	Glaxo Group Ltd	Nuevos compuestos
CN101495475A (zh)	2005-03-25	2009-07-29	葛兰素集团有限公司	制备吡啶并[2,3-d]嘧啶-7-酮和3,4-二氢嘧啶并[4,5-d]嘧啶-2(1H)-酮衍生物的方法
FR2887882B1 (fr)	2005-07-01	2007-09-07	Sanofi Aventis Sa	Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
CN101243081A (zh) *	2005-07-21	2008-08-13	霍夫曼-拉罗奇有限公司	作为PTP1B抑制剂的吡啶并[2,3-d]嘧啶-2,4-二胺化合物
BRPI0614804A2 (pt) *	2005-08-09	2011-04-12	Irm Llc	compostos e composições como inibidores de proteìna cinase
FR2896246B1 (fr)	2006-01-13	2008-08-15	Sanofi Aventis Sa	Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
EP1914234A1 (en)	2006-10-16	2008-04-23	GPC Biotech Inc.	Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors
JO2985B1 (ar)	2006-12-20	2016-09-05	Takeda Pharmaceuticals Co	مثبطات كينازmapk/erk
FR2910813B1 (fr) *	2006-12-28	2009-02-06	Sanofi Aventis Sa	Nouvelle utilisation therapeutique pour le traitement des leucemies
EP2112150B1 (en)	2008-04-22	2013-10-16	Forma Therapeutics, Inc.	Improved raf inhibitors
EP2352732B1 (en) *	2008-12-01	2013-02-20	Merck Patent GmbH	2,5-DIAMINO-SUBSTITUTED PYRIDO[4, 3-d]PYRIMIDINES AS AUTOTAXIN INHIBITORS AGAINST CANCER
GB201104267D0 (en)	2011-03-14	2011-04-27	Cancer Rec Tech Ltd	Pyrrolopyridineamino derivatives
GB201216018D0 (en)	2012-09-07	2012-10-24	Cancer Rec Tech Ltd	Pharmacologically active compounds
GB201216017D0 (en)	2012-09-07	2012-10-24	Cancer Rec Tech Ltd	Inhibitor compounds
ES2817448T3 (es)	2013-03-14	2021-04-07	Icahn School Med Mount Sinai	Compuestos de pirimidina como inhibidores de quinasas
GB201403536D0 (en)	2014-02-28	2014-04-16	Cancer Rec Tech Ltd	Inhibitor compounds
KR101671404B1 (ko) *	2014-09-02	2016-11-02	한국원자력의학원	항암 효과, 방사선 병용치료 효과 및 당뇨병 치료 효과를 갖는 피리미딘 유도체 및 이의 의학적 용도
CN107286180B (zh) *	2016-04-11	2019-07-02	上海勋和医药科技有限公司	杂代吡啶并嘧啶酮衍生物作为cdk抑制剂及其应用
GB201709840D0 (en)	2017-06-20	2017-08-02	Inst Of Cancer Research: Royal Cancer Hospital	Methods and medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK281724B6 (sk) *	1994-11-14	2001-07-10	Warner-Lambert Company	6-arylpyrido[2,3-d]pyrimidíny, ich použitie a farmaceutické prostriedky na ich báze
IL115256A0 (en) *	1994-11-14	1995-12-31	Warner Lambert Co	6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
US5620981A (en) *	1995-05-03	1997-04-15	Warner-Lambert Company	Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
KR20010043829A (ko) *	1998-05-26	2001-05-25	로즈 암스트롱, 크리스틴 에이. 트러트웨인	세포 증식 억제제로서의 비시클릭 피리미딘 및 비시클릭3,4-디히드로피리미딘

2001
- 2001-01-23 PE PE2001000072A patent/PE20011066A1/es not_active Application Discontinuation
- 2001-01-23 PA PA20018510701A patent/PA8510701A1/es unknown
- 2001-01-23 DZ DZ013266A patent/DZ3266A1/fr active
- 2001-01-23 AR ARP010100285A patent/AR030044A1/es not_active Application Discontinuation
- 2001-01-23 HU HU0204141A patent/HUP0204141A3/hu unknown
- 2001-01-23 EA EA200200643A patent/EA200200643A1/ru unknown
- 2001-01-23 YU YU50402A patent/YU50402A/sh unknown
- 2001-01-23 EP EP01900591A patent/EP1254137A1/en not_active Withdrawn
- 2001-01-23 JP JP2001561006A patent/JP4047010B2/ja not_active Expired - Fee Related
- 2001-01-23 AU AU25425/01A patent/AU2542501A/en not_active Abandoned
- 2001-01-23 WO PCT/IB2001/000069 patent/WO2001055147A1/en not_active Ceased
- 2001-01-23 EE EEP200200405A patent/EE200200405A/et unknown
- 2001-01-23 CA CA002397961A patent/CA2397961C/en not_active Expired - Fee Related
- 2001-01-23 PL PL01356802A patent/PL356802A1/xx not_active Application Discontinuation
- 2001-01-23 CZ CZ20022475A patent/CZ20022475A3/cs unknown
- 2001-01-23 IL IL15054501A patent/IL150545A0/xx unknown
- 2001-01-23 AP APAP/P/2002/002586A patent/AP2002002586A0/en unknown
- 2001-01-23 GT GT200100016A patent/GT200100016A/es unknown
- 2001-01-23 MX MXPA02007221A patent/MXPA02007221A/es not_active Application Discontinuation
- 2001-01-23 SK SK1063-2002A patent/SK10632002A3/sk not_active Application Discontinuation
- 2001-01-23 KR KR1020027009516A patent/KR20020065939A/ko not_active Ceased
- 2001-01-23 BR BR0107751-1A patent/BR0107751A/pt not_active IP Right Cessation
- 2001-01-23 OA OA1200200213A patent/OA12161A/en unknown
- 2001-01-23 CN CN01804048A patent/CN1395578A/zh active Pending
- 2001-01-24 HN HN2001000013A patent/HN2001000013A/es unknown
- 2001-01-24 SV SV2001000294A patent/SV2002000294A/es not_active Application Discontinuation
- 2001-01-24 TN TNTNSN01014A patent/TNSN01014A1/fr unknown
- 2001-01-24 CO CO01005268A patent/CO5261549A1/es not_active Application Discontinuation
2002
- 2002-06-20 BG BG106850A patent/BG106850A/bg unknown
- 2002-06-25 IS IS6443A patent/IS6443A/is unknown
- 2002-07-17 CR CR6706A patent/CR6706A/es not_active Application Discontinuation
- 2002-07-22 MA MA26736A patent/MA26868A1/fr unknown
- 2002-07-23 ZA ZA200205879A patent/ZA200205879B/en unknown
- 2002-07-24 NO NO20023527A patent/NO20023527L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EA200200643A1 (ru)	2002-12-26
OA12161A (en)	2006-05-08
PE20011066A1 (es)	2001-10-22
AP2002002586A0 (en)	2002-09-30
ZA200205879B (en)	2003-09-29
WO2001055147A1 (en)	2001-08-02
SV2002000294A (es)	2002-07-16
EP1254137A1 (en)	2002-11-06
YU50402A (sh)	2005-11-28
IS6443A (is)	2002-06-25
BG106850A (bg)	2003-02-28
GT200100016A (es)	2001-10-19
IL150545A0 (en)	2003-02-12
CN1395578A (zh)	2003-02-05
CA2397961C (en)	2008-08-26
NO20023527L (no)	2002-09-10
CA2397961A1 (en)	2001-08-02
CO5261549A1 (es)	2003-03-31
EE200200405A (et)	2003-12-15
MA26868A1 (fr)	2004-12-20
AU2542501A (en)	2001-08-07
DZ3266A1 (fr)	2001-08-02
AR030044A1 (es)	2003-08-13
JP2003523357A (ja)	2003-08-05
CR6706A (es)	2005-04-04
HN2001000013A (es)	2001-06-18
PA8510701A1 (es)	2002-12-11
NO20023527D0 (no)	2002-07-24
HUP0204141A2 (hu)	2003-04-28
JP4047010B2 (ja)	2008-02-13
HUP0204141A3 (en)	2005-03-29
SK10632002A3 (sk)	2003-06-03
KR20020065939A (ko)	2002-08-14
CZ20022475A3 (cs)	2003-03-12
BR0107751A (pt)	2002-11-12
TNSN01014A1 (fr)	2005-11-10
MXPA02007221A (es)	2002-11-29

Publication	Publication Date	Title
IL150545A0 (en)	2003-02-12	PYRIDO [2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
HRP20020798A2 (en)	2004-02-29	5-ALKYLPYRIDO[2,3-d]PYRIMIDINES TYROZINE KINASE INHIBITORS
IL159832A0 (en)	2004-06-20	4-amino-6-phenyl-pyrrolo[2,3-d] pyrimidine derivatives
PL357536A1 (en)	2004-07-26	Pyrazolo `4,3-d! pyrimidine derivatives
IL181957A0 (en)	2009-02-11	Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
IL153754A0 (en)	2003-07-06	Pyrimidine derivatives
IL158697A0 (en)	2004-05-12	4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives
IL148614A0 (en)	2002-09-12	Pteridinones as kinase inhibitors
IL149025A0 (en)	2002-11-10	5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo [4, 3-d] pyrimidin-7-ones as phosphodiesterase inhibitors
AU1041802A (en)	2002-01-30	Tetrahydro-heterocycloazepinyl pyrimidine derivatives
ZA200204510B (en)	2003-11-26	Imidazopyridine derivatives used as phosphodiesterase VII inhibitors.
PL353366A1 (en)	2003-11-17	Pyrazolo[4,3-d]pyrimidines
PL358551A1 (en)	2004-08-09	5-aminoalkyl-pyrazolo[4,3-d]pyrimidines
AU2792102A (en)	2002-06-03	Pyrimidine derivatives
PL363077A1 (en)	2004-11-15	Use of pyrazolo[4,3-d]pyrimidines
MXPA03004907A (es)	2003-09-05	Uso de pirazolo (4,3-d) pirimidinas.
AU8578501A (en)	2002-01-08	2-aminoalkyl-thieno(2,3-d)pyrimidines
IL155380A0 (en)	2003-11-23	SUBSTITUTED 3,4-DIHYDRO-PYRIDO[1,2-a] PYRIMIDINES
ZA200206528B (en)	2003-03-13	Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors.
SI1303496T1 (sl)	2007-12-31	Pirimidinski derivati
PL325356A1 (en)	1999-09-27	Novel derivative 2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidin-5-carboxylic pyrolydinamide

Legal Events

Date	Code	Title	Description
2008-09-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)